Reduced sulfur mustard-induced skin toxicity in cyclooxygenase-2 knockout and celecoxib-treated mice

Toxicology and Applied Pharmacology

Volumn 200, Issue 1, 2004, Pages 40-47

  Wormser, Uri ^a   Langenbach, Robert ^b   Peddada, Shyamal ^b   Sintov, Amnon ^c   Brodsky, Berta ^a   Nyska, Abraham ^b  

^a HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^b NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

^c BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

Author keywords

COX 2; Knockout mice; Skin; Sulfur mustard

Indexed keywords

CELECOXIB; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITOR; MUSTARD GAS;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLEEDING; BLISTER; CONTROLLED STUDY; DISEASE EXACERBATION; DISEASE SEVERITY; EAR; EAR DISEASE; EDEMA; ENZYME ANALYSIS; EPIDERMIS; EXPOSURE; HISTOPATHOLOGY; INFLAMMATION; KNOCKOUT MOUSE; MALE; MOUSE; NONHUMAN; PARAMETER; PROTEIN FUNCTION; QUANTITATIVE ANALYSIS; SKIN NECROSIS; SKIN TOXICITY; SKIN ULCER; TIME; WILD TYPE;

ANIMALS; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITORS; CYCLOOXYGENASE INHIBITORS; DERMATOLOGIC AGENTS; EDEMA; IMMUNOHISTOCHEMISTRY; ISOENZYMES; MALE; MEMBRANE PROTEINS; MICE; MICE, INBRED ICR; MICE, KNOCKOUT; MUSTARD GAS; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; PYRAZOLES; SKIN DISEASES; SULFONAMIDES;

EID: 4644317139     PISSN: 0041008X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.taap.2004.03.013     Document Type: Article

References (42)

1. Arroyo C.M., Schafer R.J., Kurt E.M., Broomfield C.A., Carmichael A.J. Response of normal human keratinocytes to sulfur mustard (HD): cytokine release using a non-enzymatic detachment procedure. Hum. Exp. Toxicol. 18:1999;1-11. (Jan.)
2. Arroyo C.M., Broomfield C.A., Hackley B.-E.J. The role of interleukin-6 (IL-6) in human sulfur mustard (HD) toxicology. Int. J. Toxicol. 20:2001;281-296
3. Babin M.C., Ricketts K., Skvorak J.P., Gazaway M., Mitcheltree L.W., Casillas R.P. Systemic administration of candidate antivesicants to protect against topically applied sulfur mustard in the mouse ear vesicant model (MEVM). J. Appl. Toxicol. 20(Suppl. 1):2000;S141-S144
4. Blaha M., Bowers W.J., Kohl J., DuBose D., Walker J., Alkhyyat A., Wong G. Effects of CEES on inflammatory mediators, heat shock protein 70A, histology and ultrastructure in two skin models. J. Appl. Toxicol. 20(Suppl. 1):2000;S101-S108
5. Casillas R.P., Kiser R.C., Truxall J.A., Singer A.W., Shumaker S.M., Niemuth N.A., Ricketts K.M., Mitcheltree L.W., Castrejon L.R., Blank J.A. Therapeutic approaches to dermatotoxicity by sulfur mustard: I. Modulaton of sulfur mustard-induced cutaneous injury in the mouse ear vesicant model. J. Appl. Toxicol. 20(Suppl. 1):2000;S145-S151
6. Gilroy D.W., Colville-Nash P.R., Willis D., Chivers J., Paul-Clark M.J., Willoughby D.A. Inducible cyclooxygenase may have anti-inflammatory properties. Nat. Med. 5:1999;698-701
7. Grosch S., Tegeder I., Niederberger E., Brautigam L., Geisslinger G. COX-2 independent induction of cell cycle arrest and apoptosis in colon cancer cells by the selective COX-2 inhibitor celecoxib. FASEB J. 15:2001;2742-2744
8. He L.K., Liu L.H., Hahn E., Gamelli R.L. The expression of cyclooxygenase and the production of prostaglandin E2 in neutrophils after burn injury and infection. J. Burn Care Rehabil. 22:2001;58-64
9. Iadecola C., Sugimoto K., Niwa K., Kazama K., Ross M.E. Increased susceptibility to ischemic brain injury in cyclooxygenase-1-deficient mice. J. Cereb. Blood Flow Metab. 21:2001;1436-1441
10. Isoherranen K., Punnonen K., Jansen C., Uotila P. Ultraviolet irradiation induces cyclooxygenase-2 expression in keratinocytes. Br. J. Dermatol. 140:1999;1017-1022
11. Langenbach R., Morham S.G., Tiano H.F., Loftin C.D., Ghanayem B.I., Chulada P.C., Mahler J.F., Lee C.A., Goulding E.H., Kluckman K.D., et al. Prostaglandin synthase 1 gene disruption in mice reduces arachidonic acid-induced inflammation and indomethacin-induced gastric ulceration. Cell. 83:1995;483-492
12. Langenbach R., Loftin C., Lee C., Tiano H. Cyclooxygenase knockout mice: models for elucidating isoform-specific functions. Biochem. Pharmacol. 58:1999;1237-1246
13. Langenbach R., Loftin C.D., Lee C., Tiano H. Cyclooxygenase-deficient mice. A summary of their characteristics and susceptibilities to inflammation and carcinogenesis. Ann. N.Y. Acad. Sci. 889:1999;52-61
14. Lee J.L., Mukhtar H., Bickers D.R., Kopelovich L., Athar M. Cyclooxygenases in the skin: pharmacological and toxicological implications. Toxicol. Appl. Pharmacol. 192:2003;294-306
15. Lefkowitz L.J., Smith W.J. Sulfur mustard-induced arachidonic acid release is mediated by phospholipase D in human keratinocytes. Biochem Biophys. Res. Commun. 295:2002;1062-1067
16. Lin H., Lin T.N., Cheung W.M., Nian G.M., Tseng P.H., Chen S.F., Chen J.J., Shyue S.K., Liou J.Y., Wu C.W., Wu K.K. Cyclooxygenase-1 and bicistronic cyclooxygenase-1/prostacyclin synthase gene transfer protect against ischemic cerebral infarction. Circulation. 105:2002;1962-1969
17. Mellor S.G., Rice P., Cooper G.J. Vesicant burns. Br. J. Plast. Surg. 44:1991;434-437
18. Morham S.G., Langenbach R., Loftin C.D., Tiano H.F., Vouloumanos N., Jennette J.C., Mahler J.F., Kluckman K.D., Ledford A., Lee C.A., et al. Prostaglandin synthase 2 gene disruption causes severe renal pathology in the mouse. Cell. 83:1995;473-482
19. Nyska A., Lomnitski L., Maronpot R., Moomaw C., Brodsky B., Sintov A., Wormser U. Effects of iodine on inducible nitric oxide synthase and cyclooxygenase-2 expression in sulfur mustard-induced skin. Arch. Toxicol. 74:2001;768-774
20. Orengo I.F., Gerguis J., Phillips R., Guevara A., Lewis A.T., Black H.S. Celecoxib, a cyclooxygenase 2 inhibitor as a potential chemopreventive to UV-induced skin cancer: a study in the hairless mouse model. Arch. Dermatol. 138:2002;751-755
21. Ostrowski J., Wocial T., Skurzak H., Bartnik W. Do altering in ornithine decarboxylase activity and gene expression contribute to antiproliferative properties of COX inhibitors? Br. J. Cancer. 88:2003;1143-1151
22. Peskar B.M., Maricic N., Gretzera B., Schuligoi R., Schmassmann A. Role of cyclooxygenase-2 in gastric mucosal defense. Life Sci. 69:2001;2993-3003
23. Petrali J.P., Oglesby-Megee S. Toxicity of mustard gas skin lesions. Microsc. Res. Tech. 37:1997;221-228
24. Rikimaru T., Nakamura M., Yano T., Beck G., Habicht G.S., Rennie L.L., Widra M., Hirshman C.A., Boulay M.G., Spannhake E.W., et al. Mediators, initiating the inflammatory response, released in organ culture by full-thickness human skin explants exposed to the irritant, sulfur mustard. J. Invest. Dermatol. 96:1991;888-897
25. Sabourin C.L.K., Petrali J.P., Casillas R.P. Alterations in inflammatory cytokine gene expression in sulfur mustard-exposed mouse skin. J. Biochem. Molec. Toxicol. 14:2000;291-302
26. Sato T., Kirimura Y., Mori Y. The co-culture of dermal fibroblasts with human epidermal keratinocytes induces increased prostaglandin E2 production and cyclooxygenase 2 activity in fibroblasts. J. Invest. Dermatol. 109:1997;334-339
27. Smith K.J. The prevention and treatment of cutaneous injury secondary to chemical warfare agents. Application of these finding to other dermatologic conditions and wound healing. Dermatol. Clin. 17:1999;41-60
28. Smith W.J., Gross C.L. Sulfur mustard medical countermeasures in a nuclear environment. Mil. Med. 167:2002;101-102
29. Smith W.L., Langenbach R. Why there are two cyclooxygenase isozymes. J Clin. Invest. 107:2001;1491-1495
30. Smith K.J., Skelton H.G., Hobson D.W., Reid F.M., Blank J.A., Hurst C.G. Cutaneous histopathologic features in weanling pigs after exposure to three different doses of liquid sulfur mustard. Am. J. Dermatopathol. 18:1996;515-520
31. Smith K.J., Casillas R., Graham J., Skelton H.G., Stemler F., Hackley B.-E.J. Histopathologic features seen with different animal models following cutaneous sulfur mustard exposure. J. Dermatol. Sci. 14:1997;126-135
32. Tiano H.F., Loftin C.D., Akunda J., Lee C.A., Spalding J., Sessoms A., Dunson D.B., Rogan E.G., Morham S.G., Smart R.C., Langenbach R. Deficiency of either cyclooxygenase (COX)-1 or COX-2 alters epidermal differentiation and reduces mouse skin tumorigenesis. Cancer Res. 62:2002;3395-3401
33. Tsuruta J., Sugisaki K., Dannenberg A.-M.J., Yoshimura T., Abe Y., Mounts P. The cytokines NAP-1 (IL-8), MCP-1, IL-1 beta, and GRO in rabbit inflammatory skin lesions produced by the chemical irritant sulfur mustard. Inflammation. 20:1996;293-318
34. US Department of Health and Human Services Guide for the Care and Use of Laboratory Animals. 1996;National Academy Press, Washington, DC
35. Vane J.R., Bakhle Y.S., Botting R.M. Cyclooxygenases 1 and 2 1280. Annu. Rev. Pharmacol. Toxicol. 38:1998;97-120
36. Wilgus T.A., Parrett M.L., Ross M.S., Tober K.L., Robertson F.M., Oberyszyn T.M. Inhibition of ultraviolet light B-induced cutaneous inflammation by a specific cyclooxygenase-2 inhibitor. Adv. Exp. Med. Biol. 507:2002;85-92
37. Wormser U. Toxicology of mustard gas. Trends Pharmacol. Sci. 12:1991;164-167
38. Wormser U., Brodsky B., Green B.S., Arad-Yellin R., Nyska A. Protective effect of povidone-iodine ointment against skin lesions induced by sulphur and nitrogen mustards and by non-mustard vesicants. Arch. Toxicol. 71:1997;165-170
39. Wormser U., Sintov A., Brodsky B., Nyska A. Topical iodine preparation as therapy against sulfur mustard-induced skin lesions. Toxicol. Appl. Pharmacol. 169:2000;33-39
40. Yourick J.J., Dawson J.S., Mitcheltree L.W. Reduction of erythema in hairless guinea pigs after cutaneous sulfur mustard vapor exposure by pretreatment with niacinamide, promethazine and indomethacin. J. Appl. Toxicol. 15:1995;133-138
41. Zhang Z., Monteiro-Riviere N.A. Comparison of integrins in human skin, pig skin, and perfused skin: an in vitro skin toxicology model. J. Appl. Toxicol. 17:1997;247-253
42. Zhang Z., Riviere J.E., Monteiro-Riviere N.A. Topical sulfur mustard induces changes in prostaglandins and interleukin-1-alpha in isolated perfused porcine skin. In Vitro Toxicol. 8:1995;149-158